News

Wall Street Horizon Partners with Informa’s BioMedTracker to provide FDA Drug Approval Dates and Pharmaceutical Intelligence to Investment Professionals

Thu February 18, 2016

Boston, MA, February 18, 2016 – Wall Street Horizon, a provider of accurate and timely corporate event dates and information for institutional investors and traders, today announced its partnership with BioMedTracker, a publisher of specialized research and healthcare intelligence and a subsidiary of Informa’s Pharma Intelligence business.

Through this partnership, BioMedTracker now supplies Wall Street Horizon with U.S. Food and Drug Administration (FDA) drug approval dates, also known as PDUFA (Prescription Drug User Fee Act) dates, which Wall Street Horizon delivers to clients through Enchilada™, its new online application that integrates more forward-looking corporate event data types than any other service available.

In addition to drug approval dates, BioMedTracker also supplies Wall Street Horizon with dates and information regarding other important events that may affect the approval or commercial potential of a drug, making Enchilada an invaluable tool for investment professionals who invest in the biotech industry or generalists looking for trading ideas.

 “We are very excited to be working with BioMedTracker to provide our clients with these drug approval dates and related market intelligence which are extremely important when investing or trading in the pharma and biotechnology sectors,” said Bruce Fador, President of Wall Street Horizon.  “BioMedTracker has been a market leader in this space for years and their accurate, timely and actionable insights will be a powerful addition to our Enchilada product.”

“We are delighted to be working with Wall Street Horizon as their source for clinical drug approval dates and information,” said Michael Hay, Head of Intelligence Products, Pharma Intelligence.  “We have a common understanding of the impact that corporate event dates can have on a company’s stock price and together we’ll be able to help a wider audience make better investment decisions, faster.”

About Wall Street Horizon
Wall Street Horizon provides institutional investors and traders with an ever expanding set of forward-looking and historical corporate event datasets including earnings dates, dividend dates, options expiration dates, splits, spinoffs and a wide variety of investor-related conferences.  With access via machine-readable feeds, the Enchilada online application or the Enchilada API, the company's data is widely recognized for its unmatched accuracy and timeliness.  For more information, please visit www.WallStreetHorizon.com or email us at info@wallstreethorizon.com.

About Pharma Intelligence and BioMedTracker
We help the world’s largest and fastest-growing businesses make confident, commercially astute decisions in the dynamic pharma and healthcare markets.  From drug discovery and development to regulatory approval and from product launch to lifecycle management, Pharma Intelligence products blend high quality data, advanced technology and industry knowledge to deliver actionable insights on the healthcare industry and public company financing markets. Whether our clients are decision makers at pharmaceutical and biotech companies, investment banks, investment funds, government agencies or academia, our intuitive platforms and analytical capabilities help our clients make informed decisions on the most critical matters that face them.  For further information, please visit:  www.biomedtracker.com

Media contact
Kathleen Ryan
Wall Street Horizon
781.994.3500 x228
kryan@wallstreethorizon.com